U.S. Tobacco Stock News

Senseonics Holdings (SENS) just posted its FY 2025 third quarter numbers, with revenue at US$8.1 million and a basic EPS loss of US$0.43, while net income excluding extra items came in at a loss of US$19.5 million. The company has seen quarterly revenue move from US$4.3 million in Q3 2024 to US$8.1 million in Q3 2025, alongside quarterly basic EPS shifting from a loss of US$0.77 to a loss of US$0.43 over the same stretch. For investors, this set of results puts the focus squarely on how...

JAKKS Pacific (JAKK) has just closed out FY 2025 with Q4 revenue of US$127.1 million and a basic EPS loss of US$0.47, while trailing 12 month EPS stood at US$0.88 on revenue of US$570.7 million. Over recent quarters the company has seen revenue move from US$321.6 million in Q3 FY 2024 to US$211.2 million in Q3 FY 2025, with basic EPS shifting from US$4.78 to US$1.78 over the same periods, setting up a results season in which investors will be watching how those earnings forecasts and margin...

Cabot (NYSE:CBT) has expanded global production of its sustainable circular reinforcing carbons in the Asia Pacific region. The expansion uses recycled tire pyrolysis oil and ISCC PLUS certification to supply circular reinforcing materials to tire manufacturers worldwide. This move is intended to support higher recycled content in tires and contribute to sustainability goals across multiple regions. For investors, this development sits at the intersection of specialty chemicals, materials...

Why GCM Grosvenor (GCMG) Is Drawing Investor Attention GCM Grosvenor (GCMG) has been drawing fresh interest as investors reassess its recent share performance alongside the firm’s latest reported figures for revenue, net income, and multi year total returns. See our latest analysis for GCM Grosvenor. At a share price of $11.70, GCM Grosvenor has seen short term share price momentum, including an 8.13% 90 day share price return, set against a 12.12% decline in 1 year total shareholder return...

HCI Group (NYSE:HCI) authorized a new $80 million share repurchase program. The company completed the IPO of its Exzeo technology platform. These actions reflect a shift in how HCI Group is using capital and its technology assets. HCI Group, an insurance and technology company, is giving investors fresh developments to watch beyond standard quarterly numbers. The new $80 million buyback authorization and the Exzeo IPO put both its balance sheet and tech capabilities in focus. For...

U.S. GoldMining Inc. recently presented at the Pre-PDAC 2026 Mining Showcase on February 27, 2026, at the Omni King Edward Hotel in Toronto, highlighting its latest project and corporate updates to an audience of industry professionals and investors. This appearance at a high-profile mining conference has amplified the company’s visibility among sector-focused investors, potentially influencing how its exploration story and future funding options are perceived. With this increased exposure...

If you are wondering whether Stewart Information Services is priced attractively or already baking in a lot of optimism, you are asking the right question before making any long term decisions. The stock last closed at US$69.95, with returns of 5.4% over 7 days, 3.7% over 30 days, around flat at 0.1% decline year to date, 2.4% over 1 year, 92.3% over 3 years and 64.6% over 5 years. Recent coverage around Stewart Information Services has focused on providing evergreen context for the stock,...

Irenic Capital Management has built an activist position in Ralliant (NYSE:RAL). The fund is urging cost cuts, a sharper focus on core businesses, and changes to capital allocation. Concerns include Ralliant’s recent cost levels and a recorded goodwill impairment. Irenic is also calling for faster share buybacks as part of its proposals. Ralliant, listed on the NYSE under ticker RAL, operates as a diversified business with exposure to several core segments that are tied to long term...

If you are wondering whether Summit Therapeutics is priced attractively or already expensive, you will want to understand how its current share price compares with different measures of underlying value. The stock recently closed at US$16.19, with returns of 0.6% over 7 days, 11.8% over 30 days, a 7.6% decline year to date, a 15.4% decline over 1 year, and a very large gain over 3 years and 189.1% over 5 years. Taken together, these figures point to a mix of past momentum and more recent...

Americold Realty Trust (NYSE:COLD) has agreed to acquire a temperature controlled facility in Houston, expanding its global footprint. The deal adds capacity in a key logistics hub that serves both domestic and international food supply chains. The company is integrating new technology across its network while working through operational challenges tied to customer contracts and concentration. Americold Realty Trust, listed as NYSE:COLD, focuses on temperature controlled warehouses and...

If you are trying to work out whether Full Truck Alliance is attractively priced or not, its current valuation metrics and what sits behind them are going to be the key things to focus on. The share price, last closing at US$9.32, has seen a 1.4% decline over the past week and is also down 5.9% over 30 days and 17.2% year to date, while the 3 year return sits at 17.2%. Recent news coverage has focused on Full Truck Alliance as a major digital freight platform in China and how it fits into...

Li Auto rolled out a major over the air update to its vehicle fleet ahead of the Chinese Spring Festival, upgrading its smart cockpit, VLA Driver large model, and smart electric features. The company supported more than 1.45 million charging sessions during the festival travel season through its charging network. Li Auto plans to launch a new Li L9 model in the coming quarter, adding to its flagship range. For investors tracking NasdaqGS:LI, these product and infrastructure updates come...

If you are wondering whether CDW is priced attractively today, it helps to step back and separate the share price story from the underlying value story. CDW closed at US$124.77, with a 1.3% gain over the last 7 days, a 1.3% decline over 30 days, a 6.3% decline year to date, and a 26.5% decline over the past year. The 3 and 5 year returns sit at 36.0% and 14.4% declines respectively. These moves have kept CDW on many investors' watchlists as they reassess how much risk they are taking on at...

Wave Life Sciences reported positive proof of concept for obesity candidate WVE-007 in Phase I, with fat loss and preservation of muscle mass. The company is preparing a pivotal Phase II trial for WVE-007 following these early clinical results. RNA editing candidates WVE-006 for alpha-1 antitrypsin deficiency and WVE-008 for liver disease are progressing toward key regulatory milestones. For investors tracking NasdaqGM:WVE, these updates come with a share price of $13.85 and a very large 3...

If you are wondering whether Avnet at around US$64.98 is still offering value or starting to look fully priced, you are asking the right question for a stock that gets a lot of attention from value focused investors. The share price has been active recently, with a 3.4% decline over the last 7 days, a 4.2% return over 30 days, and longer term returns of 31.7% year to date, 35.8% over 1 year, 55.2% over 3 years, and 87.7% over 5 years. Recent coverage of Avnet has centered on its role as a...

DRDGOLD is progressing its Vision 2028 initiative, focused on infrastructure upgrades and operational improvements across its tailings operations. The company is moving ahead with plans to link processing plants and restart deposition at key tailings storage facilities. These developments are intended to support longer term operating plans and more efficient use of existing assets. For investors watching NYSE:DRD, the Vision 2028 work sits against a share price of $38.32 and multi year...

Multiple law firms have filed class action lawsuits against Richtech Robotics (NasdaqCM:RR) alleging the company misled investors about its relationship with Microsoft. The suits claim Richtech described a collaborative and commercial partnership with Microsoft, while Microsoft has reportedly denied having a commercial relationship. Investors are focusing on potential disclosure issues, legal exposure, and the impact of these claims on Richtech's credibility and future capital...

Carter's (NYSE:CRI) has reported its first year over year revenue growth since 2021, supported by stronger retail sales and demand creation efforts. The company plans to close about 150 lower margin stores by 2028 while expanding higher priced product assortments for Gen Z and Millennial families. Carter's is also putting more emphasis on direct to consumer channels as it adjusts to changing shopping habits and cost pressures. Carter's shares recently closed at $34.95, with the stock down...

If you are wondering whether Supernus Pharmaceuticals at around US$55.09 is still offering value after its recent run, you are not alone. The stock has posted returns of 8.7% over the past 7 days, 14.4% over 30 days, 11.4% year to date and 73.6% over 1 year, with longer term returns of 43.5% over 3 years and 116.0% over 5 years. These moves sit against a backdrop of continuing interest in Supernus Pharmaceuticals as a neurology focused drug maker. Investors are paying close attention to how...

If you are looking at Medical Properties Trust and wondering whether the current share price reflects its underlying worth, you are not alone. The stock closed at US$5.65 recently, with returns of 12.5% over the last 30 days, 11.2% year to date and 4.4% over the past year, set against longer term 3 year and 5 year returns of 28.9% and 60.3% declines. Recent headlines around Medical Properties Trust have focused on its balance sheet, portfolio repositioning and how it is responding to a...

Winnebago Industries (NYSE:WGO) is working through persistent RV industry headwinds as sales have fallen over the past two years. Despite reporting revenue growth, the company has seen profitability weaken, pointing to rising pressure on its core business. This combination of softer sales trends and thinner margins is drawing attention to deeper challenges across the recreational vehicle sector. For you as an investor, Winnebago sits at the intersection of discretionary spending and outdoor...

Aardvark Therapeutics recently voluntarily paused its Phase 3 HERO trial of ARD-101 for hyperphagia in Prader-Willi Syndrome, and no longer expects to report topline data in the third quarter of 2026, with updated guidance now planned for the second quarter of 2026. The pause affects Aardvark’s lead asset in a rare disease setting where ARD-101 already holds both Orphan Drug and Rare Pediatric Disease designations from the FDA. We will now examine how the pause of the HERO Phase 3 trial for...

If you are wondering whether Enpro's current share price really reflects its underlying worth, this article walks through what the numbers actually say about value. Enpro's share price recently closed at US$264.05, with returns of 10.6% over 30 days, 20.5% year to date, 49.2% over 1 year, 155.4% over 3 years and 205.4% over 5 years. These figures may catch the eye of investors thinking about future risk and reward. Recent coverage around Enpro has focused on its role within the capital goods...

UFP Technologies (NasdaqCM:UFPT) amended its manufacturing supply agreement with Intuitive Surgical. The amendment extends the term of the partnership between the two companies. Minimum volume commitments under the agreement were increased. A new program for additional products was added to the supply arrangement. For you as an investor, this centers on UFP Technologies' role as a specialized manufacturer for the medical device sector, supplying components and solutions to a leading global...